Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,054
Total Claims
$1.0M
Drug Cost
551
Beneficiaries
$1,894
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+34%
Cost per patient vs peers
$1,894 vs $1,411 avg
+62%
Brand preference vs peers
17.2% vs 10.6% avg
Brand vs Generic
Brand: 2,245 claims · $738K
Generic: 10,780 claims · $305K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 170 | $148K |
| Apixaban | 463 | $124K |
| Rivaroxaban | 125 | $36K |
| Insulin Glargine,hum.Rec.Anlog | 66 | $21K |
| Mirabegron | 78 | $18K |
| Sacubitril/Valsartan | 50 | $18K |
| Collagenase Clostridium Hist. | 25 | $16K |
| Insulin Aspart | 51 | $16K |
| Liraglutide | 30 | $15K |
| Sitagliptin Phosphate | 45 | $13K |
| Insulin Detemir | 40 | $13K |
| Sucroferric Oxyhydroxide | 11 | $13K |
| Memantine Hcl | 132 | $13K |
| Fluticasone/Umeclidin/Vilanter | 18 | $12K |
| Fluticasone/Vilanterol | 28 | $12K |
Prescribing Profile
Patient Profile
78
Avg Age
64%
Female
2.78
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data